Biolytix to Offer Affymetrix UK's GeneChip Arrays to European Clients | GenomeWeb
NEW YORK (GenomeWeb News) – Swiss analytical services company Biolytix has bought an Affymetrix GeneChip instrument and has signed a service provider agreement with Affymetrix UK, Biolytix said today.
 
The company plans to use the GeneChip platform to offer exon and tiling arrays and SNP genotyping and gene-mapping arrays that could be used in transcriptome mapping, gene regulation, genome-wide SNP mapping, and re-sequencing.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.